# IES Holdings, Inc.: financial statements, quarterly

IESC · Nasdaq · CIK 1048268 · [Industrials](/sectors/industrials.md) · fiscal year ends Sep 30

Pages: [Overview](/companies/iesc.md) · [Financials](/companies/iesc/financials.md) · [Filings](/companies/iesc/filings.md) · [Insiders](/companies/iesc/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/iesc/financials.md?period=annual).

## Income statement

| Line item | Unit | Q4 FY2023 (2023-09-30) | Q1 FY2024 (2023-12-31) | Q2 FY2024 (2024-03-31) | Q3 FY2024 (2024-06-30) | Q4 FY2024 (2024-09-30) | Q1 FY2025 (2024-12-31) | Q2 FY2025 (2025-03-31) | Q3 FY2025 (2025-06-30) | Q4 FY2025 (2025-09-30) | Q1 FY2026 (2025-12-31) | Q2 FY2026 (2026-03-31) | Q3 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [649 d](/filings/0001048268-25-000174.md) | [634](/filings/0001048268-25-000031.md) | [706](/filings/0001048268-25-000057.md) | [768](/filings/0001048268-25-000106.md) | [776 d](/filings/0001048268-25-000174.md) | [750](/filings/0001048268-26-000037.md) | [834](/filings/0001048268-26-000086.md) | [890](/filings/0001048268-26-000130.md) | [898 d](/filings/0001048268-25-000174.md) | [871](/filings/0001048268-26-000037.md) | [974](/filings/0001048268-26-000086.md) | [1,243](/filings/0001048268-26-000130.md) |
| Cost of revenue | $m | [508 d](/filings/0001048268-25-000174.md) | [491](/filings/0001048268-25-000031.md) | [534](/filings/0001048268-25-000057.md) | [574](/filings/0001048268-25-000106.md) | [589 d](/filings/0001048268-25-000174.md) | [572](/filings/0001048268-26-000037.md) | [625](/filings/0001048268-26-000086.md) | [651](/filings/0001048268-26-000130.md) | [665 d](/filings/0001048268-25-000174.md) | [651](/filings/0001048268-26-000037.md) | [719](/filings/0001048268-26-000086.md) | [902](/filings/0001048268-26-000130.md) |
| Gross profit | $m | [141 d](/filings/0001048268-25-000174.md) | [144](/filings/0001048268-25-000031.md) | [172](/filings/0001048268-25-000057.md) | [195](/filings/0001048268-25-000106.md) | [186 d](/filings/0001048268-25-000174.md) | [178](/filings/0001048268-26-000037.md) | [209](/filings/0001048268-26-000086.md) | [240](/filings/0001048268-26-000130.md) | [233 d](/filings/0001048268-25-000174.md) | [220](/filings/0001048268-26-000037.md) | [255](/filings/0001048268-26-000086.md) | [341](/filings/0001048268-26-000130.md) |
| Selling, general and administrative | $m | [87.2 d](/filings/0001048268-25-000174.md) | [85.9](/filings/0001048268-25-000031.md) | [95.3](/filings/0001048268-25-000057.md) | [105](/filings/0001048268-25-000106.md) | [111 d](/filings/0001048268-25-000174.md) | [103](/filings/0001048268-26-000037.md) | [116](/filings/0001048268-26-000086.md) | [127](/filings/0001048268-26-000130.md) | [129 d](/filings/0001048268-25-000174.md) | [122](/filings/0001048268-26-000037.md) | [142](/filings/0001048268-26-000086.md) | [162](/filings/0001048268-26-000130.md) |
| Operating income | $m | [53.2 d](/filings/0001048268-25-000174.md) | [58.0](/filings/0001048268-25-000031.md) | [77.7](/filings/0001048268-25-000057.md) | [90.2](/filings/0001048268-25-000106.md) | [75.0 d](/filings/0001048268-25-000174.md) | [74.6](/filings/0001048268-26-000037.md) | [92.7](/filings/0001048268-26-000086.md) | [112](/filings/0001048268-26-000130.md) | [104 d](/filings/0001048268-25-000174.md) | [97.7](/filings/0001048268-26-000037.md) | [112](/filings/0001048268-26-000086.md) | [179](/filings/0001048268-26-000130.md) |
| Interest expense | $m | [0.4 d](/filings/0001048268-25-000174.md) | [0.4](/filings/0001048268-25-000031.md) | [0.4](/filings/0001048268-25-000057.md) | [0.4](/filings/0001048268-25-000106.md) | [0.1 d](/filings/0001048268-25-000174.md) | [0.5](/filings/0001048268-26-000037.md) | [0.3](/filings/0001048268-26-000086.md) | [0.5](/filings/0001048268-26-000130.md) | [0.5 d](/filings/0001048268-25-000174.md) | [0.5](/filings/0001048268-26-000037.md) | [1.5](/filings/0001048268-26-000086.md) | [1.0](/filings/0001048268-26-000130.md) |
| Income tax | $m | [12.3 d](/filings/0001048268-25-000174.md) | [15.4](/filings/0001048268-25-000031.md) | [19.4](/filings/0001048268-25-000057.md) | [22.6](/filings/0001048268-25-000106.md) | [14.8 d](/filings/0001048268-25-000174.md) | [20.0](/filings/0001048268-26-000037.md) | [26.1](/filings/0001048268-26-000086.md) | [29.5](/filings/0001048268-26-000130.md) | [21.3 d](/filings/0001048268-25-000174.md) | [28.4](/filings/0001048268-26-000037.md) | [38.3](/filings/0001048268-26-000086.md) | [51.3](/filings/0001048268-26-000130.md) |
| Net income | $m | [37.8 d](/filings/0001048268-25-000174.md) | [41.0](/filings/0001048268-24-000026.md) | [56.8](/filings/0001048268-25-000057.md) | [66.6](/filings/0001048268-25-000106.md) | [52.1 d](/filings/0001048268-25-000174.md) | [57.7](/filings/0001048268-26-000037.md) | [72.6](/filings/0001048268-26-000086.md) | [79.3](/filings/0001048268-26-000130.md) | [96.4 d](/filings/0001048268-25-000174.md) | [91.8](/filings/0001048268-26-000037.md) | [110](/filings/0001048268-26-000086.md) | [154](/filings/0001048268-26-000130.md) |
| Diluted EPS | $ per share | not reported | [1.87](/filings/0001048268-25-000031.md) | [2.29](/filings/0001048268-25-000057.md) | [2.67](/filings/0001048268-25-000106.md) | not reported | [2.72](/filings/0001048268-26-000037.md) | [3.50](/filings/0001048268-26-000086.md) | [3.81](/filings/0001048268-26-000130.md) | not reported | [4.51](/filings/0001048268-26-000037.md) | [5.44](/filings/0001048268-26-000086.md) | [7.57](/filings/0001048268-26-000130.md) |
| Basic EPS | $ per share | not reported | [1.89](/filings/0001048268-25-000031.md) | [2.32](/filings/0001048268-25-000057.md) | [2.71](/filings/0001048268-25-000106.md) | not reported | [2.76](/filings/0001048268-26-000037.md) | [3.54](/filings/0001048268-26-000086.md) | [3.86](/filings/0001048268-26-000130.md) | not reported | [4.58](/filings/0001048268-26-000037.md) | [5.51](/filings/0001048268-26-000086.md) | [7.67](/filings/0001048268-26-000130.md) |

- Revenue: us-gaap:Revenues
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss, us-gaap:ProfitLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | FY2023 (2023-09-30) | Q1 FY2024 (2023-12-31) | Q2 FY2024 (2024-03-31) | Q3 FY2024 (2024-06-30) | FY2024 (2024-09-30) | Q1 FY2025 (2024-12-31) | Q2 FY2025 (2025-03-31) | Q3 FY2025 (2025-06-30) | FY2025 (2025-09-30) | Q1 FY2026 (2025-12-31) | Q2 FY2026 (2026-03-31) | Q3 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [75.8](/filings/0001048268-24-000134.md) | [87.5](/filings/0001048268-24-000026.md) | [106](/filings/0001048268-24-000065.md) | [44.9](/filings/0001048268-24-000098.md) | [101](/filings/0001048268-25-000174.md) | [59.1](/filings/0001048268-25-000031.md) | [22.4](/filings/0001048268-25-000057.md) | [101](/filings/0001048268-26-000130.md) | [127](/filings/0001048268-26-000130.md) | [88.8](/filings/0001048268-26-000037.md) | [48.7](/filings/0001048268-26-000086.md) | [77.3](/filings/0001048268-26-000130.md) |
| Current assets | $m | [671](/filings/0001048268-24-000134.md) | [728](/filings/0001048268-24-000026.md) | [796](/filings/0001048268-24-000065.md) | [789](/filings/0001048268-24-000098.md) | [872](/filings/0001048268-25-000174.md) | [844](/filings/0001048268-25-000031.md) | [914](/filings/0001048268-25-000057.md) | [1,013](/filings/0001048268-25-000106.md) | [1,085](/filings/0001048268-26-000130.md) | [1,110](/filings/0001048268-26-000037.md) | [1,295](/filings/0001048268-26-000086.md) | [1,535](/filings/0001048268-26-000130.md) |
| Total assets | $m | [982](/filings/0001048268-25-000174.md) | [1,042](/filings/0001048268-25-000031.md) | [1,101](/filings/0001048268-25-000057.md) | [1,155](/filings/0001048268-25-000106.md) | [1,244](/filings/0001048268-25-000174.md) | [1,265](/filings/0001048268-26-000037.md) | [1,365](/filings/0001048268-26-000086.md) | [1,470](/filings/0001048268-26-000130.md) | [1,596](/filings/0001048268-26-000130.md) | [1,658](/filings/0001048268-26-000037.md) | [1,994](/filings/0001048268-26-000086.md) | [2,276](/filings/0001048268-26-000130.md) |
| Current liabilities | $m | [401](/filings/0001048268-24-000134.md) | [422](/filings/0001048268-24-000026.md) | [434](/filings/0001048268-24-000065.md) | [474](/filings/0001048268-24-000098.md) | [523](/filings/0001048268-25-000174.md) | [503](/filings/0001048268-25-000031.md) | [538](/filings/0001048268-25-000057.md) | [547](/filings/0001048268-25-000106.md) | [633](/filings/0001048268-26-000130.md) | [616](/filings/0001048268-26-000037.md) | [833](/filings/0001048268-26-000086.md) | [942](/filings/0001048268-26-000130.md) |
| Total liabilities | $m | [482](/filings/0001048268-24-000134.md) | [498](/filings/0001048268-24-000026.md) | [506](/filings/0001048268-24-000065.md) | [549](/filings/0001048268-24-000098.md) | [592](/filings/0001048268-25-000174.md) | [573](/filings/0001048268-25-000031.md) | [618](/filings/0001048268-25-000057.md) | [647](/filings/0001048268-25-000106.md) | [708](/filings/0001048268-26-000130.md) | [693](/filings/0001048268-26-000037.md) | [917](/filings/0001048268-26-000086.md) | [1,041](/filings/0001048268-26-000130.md) |
| Long-term debt | $m | [0.0](/filings/0001048268-24-000134.md) | [0.0](/filings/0001048268-24-000026.md) | [0.0](/filings/0001048268-24-000065.md) | [0.0](/filings/0001048268-24-000098.md) | [0.0](/filings/0001048268-25-000174.md) | [0.0](/filings/0001048268-25-000031.md) | [0.0](/filings/0001048268-25-000057.md) | [20.0](/filings/0001048268-25-000106.md) | [0.0](/filings/0001048268-26-000130.md) | [0.0](/filings/0001048268-26-000037.md) | [0.0](/filings/0001048268-26-000086.md) | not reported |
| Current portion of debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Short-term borrowings | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | [0.0](/filings/0001048268-26-000086.md) | not reported | [35.0](/filings/0001048268-26-000086.md) | not reported |
| Shareholders' equity | $m | [450](/filings/0001048268-25-000106.md) | [489](/filings/0001048268-25-000057.md) | [535](/filings/0001048268-25-000106.md) | [568](/filings/0001048268-25-000106.md) | [611](/filings/0001048268-26-000130.md) | [652](/filings/0001048268-26-000086.md) | [706](/filings/0001048268-26-000130.md) | [781](/filings/0001048268-26-000130.md) | [884](/filings/0001048268-26-000130.md) | [961](/filings/0001048268-26-000086.md) | [1,073](/filings/0001048268-26-000130.md) | [1,229](/filings/0001048268-26-000130.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: not reported
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q4 FY2023 (2023-09-30) | Q1 FY2024 (2023-12-31) | Q2 FY2024 (2024-03-31) | Q3 FY2024 (2024-06-30) | Q4 FY2024 (2024-09-30) | Q1 FY2025 (2024-12-31) | Q2 FY2025 (2025-03-31) | Q3 FY2025 (2025-06-30) | Q4 FY2025 (2025-09-30) | Q1 FY2026 (2025-12-31) | Q2 FY2026 (2026-03-31) | Q3 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [57.3 d](/filings/0001048268-25-000174.md) | [25.0](/filings/0001048268-25-000031.md) | [33.7 d](/filings/0001048268-25-000057.md) | [82.9 d](/filings/0001048268-25-000106.md) | [92.8 d](/filings/0001048268-25-000174.md) | [37.3](/filings/0001048268-26-000037.md) | [24.8 d](/filings/0001048268-26-000086.md) | [92.0 d](/filings/0001048268-26-000130.md) | [132 d](/filings/0001048268-25-000174.md) | [27.7](/filings/0001048268-26-000037.md) | [103 d](/filings/0001048268-26-000086.md) | [108 d](/filings/0001048268-26-000130.md) |
| Capital expenditure | $m | [6.4 d](/filings/0001048268-25-000174.md) | [6.5](/filings/0001048268-25-000031.md) | [6.8](/filings/0001048268-25-000057.md) | [17.5](/filings/0001048268-25-000106.md) | [14.3 d](/filings/0001048268-25-000174.md) | [13.2](/filings/0001048268-26-000037.md) | [17.0](/filings/0001048268-26-000086.md) | [17.1](/filings/0001048268-25-000106.md) | [20.0 d](/filings/0001048268-25-000174.md) | [46.6](/filings/0001048268-26-000037.md) | [31.8](/filings/0001048268-26-000086.md) | [44.6 d](/filings/0001048268-26-000130.md) |
| Share repurchases | $m | [0.1 d](/filings/0001048268-25-000174.md) | [0.9](/filings/0001048268-25-000031.md) | [2.3 d](/filings/0001048268-25-000057.md) | [21.1 d](/filings/0001048268-25-000106.md) | [19.7 d](/filings/0001048268-25-000174.md) | [15.7](/filings/0001048268-26-000037.md) | [20.5 d](/filings/0001048268-26-000086.md) | [5.3 d](/filings/0001048268-26-000130.md) | [0.1 d](/filings/0001048268-25-000174.md) | [17.7](/filings/0001048268-26-000037.md) | [1.7 d](/filings/0001048268-26-000086.md) | [0.1 d](/filings/0001048268-26-000130.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q1 FY2023 (2022-12-31) | Q2 FY2023 (2023-03-31) | Q3 FY2023 (2023-06-30) | Q1 FY2024 (2023-12-31) | Q2 FY2024 (2024-03-31) | Q3 FY2024 (2024-06-30) | Q1 FY2025 (2024-12-31) | Q2 FY2025 (2025-03-31) | Q3 FY2025 (2025-06-30) | Q1 FY2026 (2025-12-31) | Q2 FY2026 (2026-03-31) | Q3 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [20.4](/filings/0001048268-24-000026.md) | [20.4](/filings/0001048268-24-000065.md) | [20.4](/filings/0001048268-24-000098.md) | [20.4](/filings/0001048268-25-000031.md) | [20.5](/filings/0001048268-25-000057.md) | [20.5](/filings/0001048268-25-000106.md) | [20.2](/filings/0001048268-26-000037.md) | [20.2](/filings/0001048268-26-000086.md) | [20.1](/filings/0001048268-26-000130.md) | [20.2](/filings/0001048268-26-000037.md) | [20.2](/filings/0001048268-26-000086.md) | [20.2](/filings/0001048268-26-000130.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 19,924,356 at 2026-07-27, from the cover of the [10-Q filed 2026-07-31](/filings/0001048268-26-000130.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:31 ET. No prices; not investment advice.